share_log

Marker Therapeutics(MRKR.US):2024年Q1财报实现营收124.4万美元,前值为123.4万美元;每股收益为-0.27美元,前值为-0.57美元。

Zhitong Finance ·  May 15 19:25

Marker Therapeutics(MRKR.US):2024年Q1财报实现营收124.4万美元,前值为123.4万美元;每股收益为-0.27美元,前值为-0.57美元。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment